Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Todoerti

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|January 19, 2008
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Oncotarget|February 20, 2016
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myelomaDomenica Ronchetti, Luca Agnelli, Elisa Taiana, et al.
Advances in Hematology|December 5, 2009
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Stefano Molica, Giovanna Digiesi, Angelo Vacca, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
Expert Review of Hematology|November 1, 2016
Primary plasma cell leukemia 2.0: advances in biology and clinical managementAntonino Neri, Katia Todoerti, Marta Lionetti, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Experimental Hematology|November 27, 2012
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion moleculesMarina Bolzoni, Paola Storti, Sabrina Bonomini, et al.
Plos One|September 13, 2011
Impact of host genes and strand selection on miRNA and miRNA* expressionMarta Biasiolo, Gabriele Sales, Marta Lionetti, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|January 19, 2008
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Oncotarget|February 20, 2016
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myelomaDomenica Ronchetti, Luca Agnelli, Elisa Taiana, et al.
Advances in Hematology|December 5, 2009
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Stefano Molica, Giovanna Digiesi, Angelo Vacca, et al.
British Journal of Haematology|October 4, 2005
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myelomaKatia Todoerti, Domenica Ronchetti, Luca Agnelli, et al.
Genes, Chromosomes & Cancer|March 24, 2009
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profilesMarta Lionetti, Luca Agnelli, Laura Mosca, et al.
Discover Oncology|November 11, 2022
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myelomaDomenica Ronchetti, Vanessa Katia Favasuli, Ilaria Silvestris, et al.
Expert Review of Hematology|November 1, 2016
Primary plasma cell leukemia 2.0: advances in biology and clinical managementAntonino Neri, Katia Todoerti, Marta Lionetti, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Experimental Hematology|November 27, 2012
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion moleculesMarina Bolzoni, Paola Storti, Sabrina Bonomini, et al.
Plos One|September 13, 2011
Impact of host genes and strand selection on miRNA and miRNA* expressionMarta Biasiolo, Gabriele Sales, Marta Lionetti, et al.
Pageof 11